| MeSH term | MeSH ID | Detail |
|---|---|---|
| Heart Failure | D006333 | 36 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenoma | D000236 | 40 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Liver Neoplasms, Experimental | D008114 | 46 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
Sphingosine 1-phosphate
Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
Cross Reference
Introduction
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Sphingosine 1-phosphate?
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
PubChem Associated disorders and diseases
What pathways are associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Sphingosine 1-phosphate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Sphingosine 1-phosphate?
Knock-out
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Sphingosine 1-phosphate
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rieken S et al. | Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). | 2006 | J. Biol. Chem. | pmid:17023430 |
| Kabashima K et al. | Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. | 2006 | J. Exp. Med. | pmid:17101733 |
| Wendler CC and Rivkees SA | Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. | 2006 | Dev. Biol. | pmid:16434032 |
| Wattenberg BW et al. | The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. | 2006 | J. Lipid Res. | pmid:16520486 |
| Yan L et al. | 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. | 2006 | Bioorg. Med. Chem. Lett. | pmid:16621543 |
| Venkataraman K et al. | Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. | 2006 | Biochem. J. | pmid:16623665 |
| Kono M et al. | Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. | 2006 | J. Biol. Chem. | pmid:16380386 |
| von Otte S et al. | Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. | 2006 | J. Biol. Chem. | pmid:16365044 |
| Alewijnse AE and Michel MC | Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? | 2006 | Br. J. Pharmacol. | pmid:16402045 |
| Schmidt H et al. | LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. | 2006 | Prostaglandins Other Lipid Mediat. | pmid:17085324 |
| Hait NC et al. | Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. | 2006 | Biochim. Biophys. Acta | pmid:16996023 |
| Minshall RD and Malik AB | Transport across the endothelium: regulation of endothelial permeability. | 2006 | Handb Exp Pharmacol | pmid:16999218 |
| Idzko M et al. | Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. | 2006 | J. Clin. Invest. | pmid:17080194 |
| von Wenckstern H et al. | The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. | 2006 Jul-Aug | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:16830220 |
| Shimizu T et al. | Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. | 2007 | Circ. Res. | pmid:17872461 |
| Kunisawa J et al. | Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. | 2007 | J. Exp. Med. | pmid:17875673 |
| Martino A | Sphingosine 1-phosphate as a novel immune regulator of dendritic cells. | 2007 | J. Biosci. | pmid:17954981 |
| Alemany R et al. | Regulation and functional roles of sphingosine kinases. | 2007 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:17242884 |
| Kim M et al. | Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. | 2007 | Am. J. Physiol. Renal Physiol. | pmid:17898040 |
| Tan SY et al. | Aberrant Gi protein coupled receptor-mediated cell survival signaling in rheumatoid arthritis B cell lines. | 2007 | Front. Biosci. | pmid:17127411 |
| Alvarez SE et al. | Autocrine and paracrine roles of sphingosine-1-phosphate. | 2007 | Trends Endocrinol. Metab. | pmid:17904858 |
| Deng Q et al. | Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. | 2007 | Mol. Pharmacol. | pmid:17170199 |
| Braun A et al. | Paucity of pericytes in germinal matrix vasculature of premature infants. | 2007 | J. Neurosci. | pmid:17978043 |
| Hinson JS et al. | Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16997888 |
| Van Brocklyn JR | Sphingolipid signaling pathways as potential therapeutic targets in gliomas. | 2007 | Mini Rev Med Chem | pmid:17979800 |
| Oskouian B and Saba J | Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again. | 2007 | Cell Cycle | pmid:17361098 |
| Nyalendo C et al. | Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. | 2007 | J. Biol. Chem. | pmid:17389600 |
| Okazaki M et al. | Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. | 2007 | Am. J. Transplant. | pmid:17391120 |
| Milstien S et al. | Sphingosine 1-phosphate in neural signalling and function. | 2007 | Acta Paediatr Suppl | pmid:17391440 |
| Michel MC et al. | Vascular effects of sphingolipids. | 2007 | Acta Paediatr Suppl | pmid:17391441 |
| Goetzl EJ et al. | Sphingosine 1-phosphate as an intracellular messenger and extracellular mediator in immunity. | 2007 | Acta Paediatr Suppl | pmid:17391442 |
| Lobo MK et al. | Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. | 2007 | Nat. Neurosci. | pmid:17934457 |
| Peters SL and Alewijnse AE | Sphingosine-1-phosphate signaling in the cardiovascular system. | 2007 | Curr Opin Pharmacol | pmid:17280869 |
| Tellier E et al. | Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. | 2007 | Mol. Cell. Biol. | pmid:17283058 |
| Kihara A et al. | Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. | 2007 | Prog. Lipid Res. | pmid:17449104 |
| Samy ET et al. | Cutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. | 2007 | J. Immunol. | pmid:17947634 |
| Watterson KR et al. | Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone. | 2007 | FASEB J. | pmid:17449719 |
| Czeloth N et al. | Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. | 2007 | J. Immunol. | pmid:17947659 |
| Shin JH et al. | Sphingosine 1-phosphate triggers apoptotic signal for B16 melanoma cells via ERK and caspase activation. | 2007 | J. Korean Med. Sci. | pmid:17449940 |
| Jongsma M et al. | Validation of a rapid, non-radioactive method to quantify internalisation of G-protein coupled receptors. | 2007 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:17497135 |
| Zabielski P et al. | Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver. | 2007 | Prostaglandins Other Lipid Mediat. | pmid:17499747 |
| Olivera A et al. | The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. | 2007 | Immunity | pmid:17346996 |
| Catarzi S et al. | Sphingosine 1-phosphate stimulation of NADPH oxidase activity: relationship with platelet-derived growth factor receptor and c-Src kinase. | 2007 | Biochim. Biophys. Acta | pmid:17349748 |
| Park KS et al. | S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17349972 |
| Zhao M et al. | [The effects of sphingosine-1 1-phosphate (SIP) on the action potential and contractile in guinea pig ventricular myocardium]. | 2007 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21171361 |
| Murph M and Mills GB | Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. | 2007 | Expert Rev Mol Med | pmid:17935635 |
| Schwab SR and Cyster JG | Finding a way out: lymphocyte egress from lymphoid organs. | 2007 | Nat. Immunol. | pmid:18026082 |
| Lee YM et al. | A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). | 2007 | Prostaglandins Other Lipid Mediat. | pmid:17991617 |
| Leiber D et al. | Exogenous sphingosine 1-phosphate and sphingosine kinase activated by endothelin-1 induced myometrial contraction through differential mechanisms. | 2007 | Am. J. Physiol., Cell Physiol. | pmid:16956968 |
| Tani M et al. | Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. | 2007 | Cell. Signal. | pmid:16963225 |